Published in Case Rep Oncol on June 01, 2013
Cesarean scar ectopic pregnancies: etiology, diagnosis, and management. Obstet Gynecol (2006) 3.02
Obstetric iatrogenic arterial injuries of the uterus: diagnosis with US and treatment with transcatheter arterial embolization. Radiographics (2002) 1.91
Efficacy of embolization in traumatic uterine vascular malformations. J Vasc Interv Radiol (2003) 1.54
Arteriovenous malformations of the uterus. Acta Radiol (2009) 1.30
Arteriovenous malformation as a consequence of a scar pregnancy. Acta Obstet Gynecol Scand (2009) 0.97
Current knowledge and management of vascular anomalies, II: malformations. Arch Facial Plast Surg (2011) 0.97
Congenital vascular malformation of the uterus in a stillborn: a case report. Hum Pathol (1995) 0.85
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol (2004) 3.57
Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res (2002) 2.37
Cytoreductive surgery for advanced ovarian cancer: quo vadis? Oncology (Williston Park) (2011) 2.05
HPV communication: review of existing research and recommendations for patient education. CA Cancer J Clin (2004) 1.88
The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. J Pathol (2010) 1.70
Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol (2012) 1.53
Laparoscopic surgery for endometrial cancer: why don't all patients go home the day after surgery? J Minim Invasive Gynecol (2011) 1.37
Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples. Gynecol Oncol (2004) 1.33
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol (2003) 1.20
Cervical cancer screening and prevention in low-resource settings. Clin Obstet Gynecol (2013) 1.16
The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. Gynecol Oncol (2004) 1.14
Beneficial effects of hypnosis and adverse effects of empathic attention during percutaneous tumor treatment: when being nice does not suffice. J Vasc Interv Radiol (2008) 1.10
Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer. Front Biosci (Landmark Ed) (2011) 1.08
Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res (2004) 1.05
Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled clinical trial. J Altern Complement Med (2009) 1.05
Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol (2009) 1.01
Epithelioid angiosarcoma of the uterus: a review of management. Arch Gynecol Obstet (2008) 1.01
Phase II trial of anastrozole in women with asymptomatic müllerian cancer. Gynecol Oncol (2003) 1.00
Racial disparities in cervical cancer survival over time. Cancer (2013) 0.94
Case records of the Massachusetts General Hospital. Case 8-2010. A 22-year-old woman with hypercalcemia and a pelvic mass. N Engl J Med (2010) 0.93
Gemcitabine pulmonary toxicity in ovarian cancer. Oncologist (2008) 0.92
The Role of Lymphadenectomy Versus Sentinel Lymph Node Biopsy in Early-stage Endometrial Cancer: A Review of the Literature. Am J Clin Oncol (2016) 0.90
Correlates of the preoperative level of CA125 at presentation of ovarian cancer. Gynecol Oncol (2010) 0.89
A case of Müllerian adenosarcoma of the uterus treated with liposomal doxorubicin. Gynecol Oncol (2003) 0.88
Transjugular intrahepatic portosystemic shunt for acute variceal hemorrhage. Tech Vasc Interv Radiol (2009) 0.88
Prognostic determinants in patients with uterine and ovarian carcinosarcoma. J Reprod Med (2013) 0.86
Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer. Gynecol Oncol (2009) 0.86
Case records of the Massachusetts General Hospital. Case 10-2009. A 23-year-old woman with an abnormal Papanicolaou smear. N Engl J Med (2009) 0.85
Angiographic evaluation and management of acute gastrointestinal hemorrhage. World J Gastroenterol (2012) 0.85
Abdominal radical trachelectomy: Success and pitfalls in a general gynecologic oncology practice. Gynecol Oncol (2009) 0.84
Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review. Int J Gynecol Cancer (2011) 0.83
Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review. Int J Gynecol Cancer (2012) 0.82
A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Gynecol Oncol (2005) 0.81
HPV Reflex Testing in Menopausal Women. Patholog Res Int (2011) 0.81
Changing Trends in Lymphadenectomy for Endometrioid Adenocarcinoma of the Endometrium. Obstet Gynecol (2015) 0.81
Sister Society Meeting on Global Education Development and Collaboration: Meeting Report. Int J Gynecol Cancer (2016) 0.81
Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer. Ann Surg Oncol (2011) 0.80
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies. Gynecol Oncol (2004) 0.80
Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Gynecol Oncol (2013) 0.80
Addendum of newer anticoagulants to the SIR consensus guideline. J Vasc Interv Radiol (2013) 0.79
Caring for women with gynecologic cancers around the world: the need for global health training in gynecologic oncology fellowship programs. Am J Clin Oncol (2012) 0.79
Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis. Am J Clin Oncol (2016) 0.78
Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma. Gynecol Oncol (2008) 0.78
Image optimization during endovascular aneurysm repair. AJR Am J Roentgenol (2012) 0.78
Endometrial cancer with concurrent ovarian malignancy: assessing the risks. Obstet Gynecol (2005) 0.76
Intravascular ultrasound-guided inferior vena cava filter placement using a single-puncture technique in 99 patients. Vasc Endovascular Surg (2013) 0.76
Endometrial stromal sarcoma: a clinicopathologic study of 29 patients. J Reprod Med (2015) 0.76
Intraoperative Radiation Therapy in the Management of Gynecologic Malignancies. Am J Clin Oncol (2016) 0.76
Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time. Am J Obstet Gynecol (2013) 0.76
Postembolization syndrome: changes in white blood cell counts immediately after uterine artery embolization. J Vasc Interv Radiol (2008) 0.76
Hypercalcemia associated with a malignant brenner tumor arising from a mature cystic teratoma. Case Rep Oncol (2012) 0.75
Laparoscopy versus laparotomy in the surgical management of gynecologic disease in older women: a shifting paradigm. Menopause (2010) 0.75
An unusual presentation of endometrial cancer: a case report and literature review. Arch Gynecol Obstet (2008) 0.75
Evolution of surgical management of early-stage endometrial cancer. Am J Obstet Gynecol (2011) 0.75
Case records of the Massachusetts General Hospital. Case 14-2013. A 70-year-old woman with vaginal bleeding. N Engl J Med (2013) 0.75
Suffer little children. J Pastoral Care Counsel (2012) 0.75
Preliminary experience with Option inferior vena cava filter. Vasc Endovascular Surg (2012) 0.75
Comparison of outcomes in patients with early-stage mucinous endometrial cancer and those with endometrioid endometrial cancer, with and without adjuvant therapy. J Reprod Med (2015) 0.75
Measuring success in ovarian cancer risk reducing strategies. Cancer (2011) 0.75
Prospective analysis of an interprofessional team training program using high-fidelity simulation of contrast reactions. AJR Am J Roentgenol (2015) 0.75
Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy. Obstet Gynecol (2017) 0.75
The risk of squamous cell carcinoma in persistent vulvar ulcers. Menopause (2011) 0.75
ACR Appropriateness Criteria® Acute Pelvic Pain in the Reproductive Age Group. Ultrasound Q (2016) 0.75